The Myth of the Longevity Biotech Industry

Nathan Cheng (@realNathanCheng), program director for On Deck Longevity, joins Erik on this episode to discuss:

- The key breakthroughs in aging research in the past.

- Why we're still waiting for the first success story in humans, and why he predicts the first drug will be approved in the next ten years.

- Why the space has plenty of capital but not enough founders.

- The challenges and roadblocks in the space.

- Common misconceptions about longevity.

- Who should think about applying to the program.

Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. 

Check us out on the web at www.villageglobal.vc or get in touch with us on Twitter @villageglobal.

Want to get updates from us? Subscribe to get a peek inside the Village. We’ll send you reading recommendations, exclusive event invites, and commentary on the latest happenings in Silicon Valley. www.villageglobal.vc/signup